The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review
Open Access
- 9 July 2020
- journal article
- review article
- Published by Wiley in Journal of Diabetes Research
- Vol. 2020, 1-6
Abstract
Sarcopenia is a geriatric syndrome characterized by decline of skeletal muscle mass and function. Contributing factors include nutritional, genetic, inflammatory, and endocrinal factors. The reported prevalence of sarcopenia in type 2 diabetes mellitus is high, especially in patients with poor glycemic control. Additionally, antidiabetic agents may alter the balance between protein synthesis and degradation through various mechanisms of skeletal muscle mass regulation. This study reviewed the literature on the pathogenesis of sarcopenia in diabetes mellitus and the current understanding of whether antidiabetic agents contribute positively or negatively to sarcopenia and muscle wasting.Keywords
This publication has 58 references indexed in Scilit:
- Mechanisms regulating skeletal muscle growth and atrophyThe FEBS Journal, 2013
- Resistance Training and Pioglitazone Lead to Improvements in Muscle Power During Voluntary Weight Loss in Older AdultsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2013
- AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling networkAgeing Research Reviews, 2012
- Glucagon-Like Peptide 1 Recruits Microvasculature and Increases Glucose Use in Muscle via a Nitric Oxide–Dependent MechanismDiabetes, 2012
- Insulin Sensitizers May Attenuate Lean Mass Loss in Older Men With DiabetesDiabetes Care, 2011
- The Effect of Pioglitazone and Resistance Training on Body Composition in Older Men and Women Undergoing Hypocaloric Weight LossObesity, 2011
- Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 DiabetesDiabetes Care, 2010
- The KATP channel is a molecular sensor of atrophy in skeletal muscleThe Journal of Physiology, 2010
- Nuclear factor-kappa B signaling in skeletal muscle atrophyJournal of Molecular Medicine, 2008
- Pioglitazone Enhances Mitochondrial Biogenesis and Ribosomal Protein Biosynthesis in Skeletal Muscle in Polycystic Ovary SyndromePLOS ONE, 2008